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Protein foldingated protein in the cell is associated with the pathology of many diseases and
constitutes a major concern in protein production. Intracellular aggregates have been traditionally regarded as
nonspeciﬁc associations of misfolded polypeptides. This view is challenged by studies demonstrating that, in
vitro, aggregation often involves speciﬁc interactions. However, little is known about the speciﬁcity of in vivo
protein deposition. Here, we investigate the degree of in vivo co-aggregation between two self-aggregating
proteins, Aβ42 amyloid peptide and foot-and-mouth disease virus VP1 capsid protein, in prokaryotic cells. In
addition, the ultrastructure of intracellular aggregates is explored to decipher whether amyloid ﬁbrils and
intracellular protein inclusions share structural properties. The data indicate that in vivo protein aggregation
exhibits a remarkable speciﬁcity that depends on the establishment of selective interactions and results in the
formation of oligomeric and ﬁbrillar structures displaying amyloid-like properties. These features allow
prokaryotic Aβ42 intracellular aggregates to act as effective seeds in the formation of Aβ42 amyloid ﬁbrils.
Overall, our results suggest that conserved mechanisms underlie protein aggregation in different organisms.
They also have important implications for biotechnological and biomedical applications of recombinant
polypeptides.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionThe intracellular aggregation of polypeptides is a pathogenic
feature of cellular degeneration in most neurodegenerative disorders
[1]. Intracellular protein aggregates are formed when misfolded poly-
peptides accumulate in the cells due to malfunctioning or overloading
of the protein quality control pathways or of the components of the
degradative pathway [2]. The recombinant expression of proteins also
tends to saturate the cell foldingmachinery, resulting frequently in the
mistargeting of the heterologous polypeptide into aggregates that
accumulate as cytoplasmic aggresomes in eukaryotes [3] or inclusion
bodies (IBs) in prokaryotes [4]. These protein aggregates are usually
insoluble and metabolically stable under physiological conditions.
Their formation has been typically considered to be through non-
speciﬁc association of hydrophobic patches on the surface of folding
intermediates. Therefore,misfolded polypeptides have been suggested
to be harmful to cells due to their tendency to coaggregate with andBlue Fluorescent Protein; CHC,
nance Energy Transfer; FT-IR,





l rights reserved.thus trap unrelated proteins that may transiently exhibit complemen-
tary surfaces. However, several in vitro studies question this classical
view by demonstrating the establishment of speciﬁc intermolecular
interactions between deﬁned protein regions under controlled
aggregation conditions [5,6]. These data suggest selectiveness during
aggregation of puriﬁed and denatured polypeptides in dilute solution,
but few information is available about the determinants of protein
aggregation in the highly complex intracellular environment, where
many cellular factors might alter dramatically the aggregation
behavior of polypeptides [7]. These include the high protein concen-
tration, molecular crowding effects, the action of molecular chaper-
ones and proteases and the continuous supply of unfolded or partially
folded polypeptides by the ongoing translational machinery. This
difference between in vitro and in vivo experimental conditions
constitutes an important barrier for the molecular understanding of
protein aggregation in living organisms [8]. Kopito and coworkers have
demonstrated that the formation of cytoplasmic protein aggregates in
animal cells exhibits a remarkable speciﬁcity [9].We sought to analyze
if the same selectivity applies in the in vivo formation of bacterial IBs
where protein accumulation is likely to be a diffusion-limited process
not mediated by cellular substructures in contrast to eukaryotic
backgrounds [10]. To this aim, two aggregation-prone polypeptides
have been biosynthetically tagged with different ﬂuorescent proteins
and co-expressed in Escherichia coli cells. The Alzheimer-related
peptide Aβ42 has been fused to the enhanced versions of Blue and
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and-mouth disease virus VP1 capsid protein (Vp1) has been fused to
enhanced GFP (Vp1-GFP). All these protein fusions accumulate mainly
as cytoplasmic IBswhen theyare expressed in E. coli and can be tracked
due to their ﬂuorescence [11].
IBs have been thought to be amorphous precipitates devoid of
any molecular structure, quite the opposite to the almost crystalline
packing of polypeptides in extracellular amyloid ﬁbrils [12]. None-
theless, recent studies run against this view by demonstrating the
recurrent presence of intermolecular β-sheet secondary structure in
IBs [13,14]. In addition, Thioﬂavin-T (Th-T) and Congo red, two dyes
used to detect intermolecular β-sheet architecture in aggregates,
bind to both amyloid ﬁbrils and IBs [14,15]. These data indicate
certain resemblance in the inner organization of both types of
aggregates and suggest an intriguing possibility: the existence of
amyloid-like polypeptidic conformations inside bacterial cytoplas-
mic aggregates. In this work, using Aβ42 as a model peptide,
different techniques have been applied to explore the conforma-
tional features and the existence of ordered ﬁbrillar structure in
prokaryotic aggregates. Our data suggest a conserved and speciﬁc
mechanism underlying protein aggregation in prokaryotic and
eukaryotic cells.
2. Materials and methods
2.1. Strain, plasmids, and culture conditions
The plasmids encoding for Aβ42-GFP and Vp1-GFP were as
previously described [16,17]. DNA encoding Aβ42-BFP was obtained
by site-directed mutagenesis of Aβ42-GFP using the QuickChange kit
from Stratagene. Forward and reverse primers were designed to
introduce the Y66H and Y144F mutations in GFP. Aβ42-GFP was also
cloned in pBAT4 (EMBL). The plasmid encoding for Aβ42 peptide was
obtained by mutating to two stop codons the two ﬁrst amino acids in
the linker connecting Aβ42 and GFP moieties in the Aβ42-GFP fusion
All constructs were veriﬁed by DNA sequencing. Competent E. coli
BL21(D3) cells were transformed with plasmids encoding for the
desired fusion proteins and incubated in Luria–Bertani medium (LB)
with the appropriate antibiotics (50 μg/ml amp or 35 μg/ml knm) at
37 °C and recombinant gene expression was induced when A600 nm
reached 0.6, by adding 1 mM isopropyl-β-D-thiogalactopyranoside
(IPTG) and incubating at 37 °C for 16 h. In co-expression experiments
cells were simultaneously transformed with two compatible plasmids
expressing the desired combination of fusion proteins and selected in
LB containing 50 μg/ml amp and 35 μg/ml knm.
2.2. Protein expression analysis
Cellular soluble and insoluble fractions were isolated using the
BugBuster® Protein Extraction Reagent from Novagene according to
the procedure recommended by the manufacturer. Fractions were
mixed with loading buffer containing 9% SDS and 15% β-mercap-
toethanol and boiled for 10 min. Protein electrophoresis in 15%
polyacrylamide gels were performed as described [18].
2.3. IBs puriﬁcation and denaturation
IBs were puriﬁed from cell extracts 16 h after the induction of gene
expression, by detergent-based procedures as described [19]. Brieﬂy,
cells were harvested by centrifugation at 12000 ×g (at 4 °C) for 15 min
and resuspended in 200 μl of lysis buffer (50 mM Tris–HCl, pH 8,1 mM
EDTA, 100 mM NaCl), plus 30 μl of 100 mM PMSF and 6 μl of 10 mg/ml
lysozyme. After 30 min of incubation at 37°C under gentle agitation,
NP-40 was added at 1% (v/v) and the mixture incubated at 4 °C for
30 min. Then, 3 μl of DNase I from a 1 mg/ml stock (25 μg/ml ﬁnal
concentration) and 3 μl of 1 M MgSO4 were added and the resultingmixture was further incubated at 37 °C for 30 min. Protein aggregates
were separated by centrifugation at 12 000 ×g for 15 min at 4 °C.
Finally, IBs were washed once with the same buffer containing 0.5%
Triton X-100 and once with sterile PBS. After a ﬁnal centrifugation at
12000 ×g for 15 min, pellets were stored at −80 °C until analysis.
To discard the presence of nucleic acids in IBs, they were
digested with DNAse and RNAse A (25 μg/ml) for 1 h at 37 °C in the
presence of MgSO4 (10 mM). Afterwards, IBs were centrifuged and
dissolved in PBS. No signiﬁcant spectral, morphological or compo-
sitional differences between untreated and treated IBs could be
detected.
Protein in IBs was quantiﬁed after overnight denaturation in 8 M
urea by the Bradford assay. The kinetics of IBs denaturation by GuHCl
were measured as described [20]. Double-exponential decay curves
were ﬁtted to the data using Sigmaplot non-linear regression software
(Jandel Scientiﬁc, San Rafael, CA, USA)
2.4. Confocal microscopy analysis
Cells expressing the different constructs were ﬁxed with 0.1%
formaldehyde and stored at 4 °C until observed. Photographs were
taken using a Leica TCS SP2 confocal microscope (excitation wave-
lengths 488 nm (GFP) and 409–468 nm (BFP) and emissionwavelength
500 to 600 nm in both cases; optical lens magniﬁcation 63×; 1024 by
1024 pixels; zoom 4).
2.5. Fret analysis
2.5.1. By confocal microscopy
Cells were ﬁxed and imaged as described above. The analysis of
digitized microscope images allowed selection of regions of interest
(ROI) in the cells. To record BFP emission spectra, the BFP donor in
the selected ROI was excited with both 351 nm and 364 nm laser
lines and emission spectra were generated by scanning the ROI
and recorded using Leica Confocal Software (LCS). To record GFP
emission spectra, the GFP-ﬂuorophore was excited by the 488-nm
laser line. For GFP acceptor photobleaching experiments, cells were
photobleached exciting at 488 nm. Fluorescence emission spectra
were recorded before and after photobleaching following BFP
excitation at 409–468 nm to assess changes in donor GFP
ﬂuorescence. FRET acceptor photobleaching software was used to
document that FRET occurred by showing that the intensity of
donor BFP ﬂuorescence increased after the GFP acceptor was
photobleached. FRET efﬁciency (EFRET) is calculated using the
formula EFRET=(Ipost− Ipre) / Ipost, where Ipre and Ipost are the
ﬂuorescence intensities of BFP before and after photobleaching,
respectively. The percentage of FRET was measured in one hundred
samples in each case (Aβ42-BFP/Aβ42-GFP or Aβ42-BFP/Vp1-GFP),
was averaged and plotted.
2.5.2. By ﬂuorescence spectrometry
18 h after protein expression induction, cells expressing different
protein fusions were washed with PBS and diluted to A600 nm=0.01.
Their ﬂuorescence emission was measured from 420–560 nm at 25 °C
using an excitation wavelength of 389 nm.
2.6. Transmission electronic microscopy
IBs (50μg/ml) were digested using PK (20 μg/ml) at 37 °C 50 mM
Tris–HCl and 150 mM NaCl, pH=8. At different times of digestion,
the samples were centrifuged and the insoluble part was
resuspended in water, deposited on carbon-coated copper grids,
and left for 5 min. The grids were washed with distilled water and
stained with 2% (w/v) uranyl acetate for another 2 min before
analysis using a Hitachi H-7000 transmission electron microscope
operating at 75 kV.
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Thioﬂavine-T binding assays were carried out using 100 μl-aliquots
from 100 μg/ml protein samples. These aliquots were diluted in buffer
(10 mM sodium phosphate, (pH 7), 150 mM NaCl) containing 65 μM
Th-T, and adjusted to a ﬁnal volume of 1 ml. PK was added at a ﬁnal
concentration of 1 μg/ml. Fluorescence emission spectra were
recorded using an excitation wavelength ﬁxed at 440 nm. Apertures
of 10 nm were ﬁxed in both excitation and emission slits.
2.8. FTIR spectroscopy
The Aβ42-GFP ﬁbrillar core was analyzed using a Bruker Tensor 27
FT-IR Spectrometer (Bruker Optics Inc) with a Golden Gate MKII ATR
accessory. Each spectrum consisted of 20 independent scans,
measured at a spectral resolution of 2 cm−1 within the 1800–
1500 cm−1 range. All Spectral data are acquired and normalized
using the OPUS MIR Tensor 27 software. Second derivatives of the
spectra were used to determine the frequencies at which the different
spectral components were located.
2.9. Atomic force microscopy
2.9.1. AFM imaging
Imaging was performed with a commercial MultiMode atomic
force microscope controlled by Nanoscope IV electronics (Digital
Instruments, Santa Barbara, CA), equippedwith either a 12-μmscanner
(E-scanner) or a 120-µm scanner (J-scanner). All images were taken in
liquid using a tapping mode liquid cell without the O-ring seal. Oxide-
sharpened pyramidal Si3N4 tips mounted on triangular 100-μm-long
cantilevers (k=0.08 N/m) were purchased from Olympus (Tokyo,
Japan). The liquid cell and the tip were cleaned with ethanol and
thoroughly rinsed with deionized water before use. For imaging, the
microscope head was placed on a vibration-isolated plate. 20 μl of the
sample were allowed to adsorb for about 15 min at room temperature
on highly ordered pyrolytic graphite (Nt-MDT Co., Zelenograd,
Moscow, Russia) and ﬁnally overlaid with 100 μl of incubation buffer.
2.9.2. Force spectroscopy
The resistance of IBs to indentation was measured by acquiring
force curves with the AFM in force spectroscopy experiments. A
commercial AFM (MFP-3D, Asylum Research, Santa Barbara, CA)
integrated with a Nikon Eclipse TE 2000-S inverted ﬂuorescence
microscope was used to study the rupture forces and the ﬂuorescence
visualization of IBs. Tapping mode imaging and force measurements
were performed in PK digestion buffer solution using the tips
described above. Prior to each experiment, 20 μl of the sample were
allowed to adsorb for about 15 min at room temperature on poly
(methyl methacrylate) (PMMA). All indentations were made using a
displacement rate of 2 μm/s.
2.10. Mass spectrometry analysis of the IBs proteolysis
IBs of Aβ42-GFP were digested as described above for 20 h. The
reaction mixture was centrifuged for 10 min at 10000 ×g, the pellet
was resuspended in GuHCl 6Mand left for 12 h. The samplewasmixed
with an equal volume of the matrix: 2',6'-Dihydroxyacetophenone
(Fluka). This matrix was prepared in a solution of 30% acetonitrile in
20 mM ammonium citrate. The samples were loaded on MALDI plates
by the dried droplet method. The calibration standards were from
Bruker and the MALDI-TOF mass spectrometer was a Bruker Ultraﬂex.
2.11. Analysis of in vivo Aβ42-GFP oligomerization
For the analysis of Aβ42-GFP oligomers formation, cells were col-
lected at different timepoints after induction of protein expression andanalyzed by Western blot. The protein content of cellular fractions
was resolved on 10% SDS-PAGE gels, transferred on to PVDF
membranes, and recombinant proteins detected with a polyclonal
anti-GFP antibody (Sigma). The membranes were developed with the
ECL method. The existence of strong non covalent intermolecular
contacts stabilizing the oligomers, was demonstrated by boiling
the cellular fractions for 10 min in the presence of a reducing agent
(15%β-mercaptoethanol) and SDS (9%) before electrophoretic analysis.
2.12. Seeding of Aβ42 amyloid ﬁbrils
A stock solution of 100 μM of peptide Aβ42 was prepared in
1,1,1,3,3,3-hexaﬂuoro-2-propanol (HFIP) and the solution was incu-
bated at room temperature for 10 min. The solution was divided into
aliquots of 100 μl fromwhich HFIP was removed by evaporation under
a gentle stream of nitrogen, ﬁnally storing them at −20 °C for later use.
Before the experiment, each aliquot was resuspended in 50 μl of
dimethyl sulfoxide (DMSO) and sonicated for 15 min. Sonication was
critical to remove any traces of undissolved seeds that may resist
solubilization. These aliquots of Aβ42 stock were dissolved in 750 μl of
10mMTris-HCl, pH 7.4. Then, Th-Twas dissolved until aﬁnal volume of
25 μM. In the control (aggregation of Aβ42 mononers), Tris-HCl was
added to a ﬁnal volume of 1ml. In the seeding assay, a solution Aβ42—
only IBs (to a ﬁnal OD350=0.125) was also added. As a positive control,
one reaction was performed under the presence of preformed Aβ42
ﬁbers (10% w/w). The ﬂuorescence emission at 480 nm (exciting at
445 nm) was measured at 1-min intervals in a ﬂuorescence spectro-
photometer using quartz microcuvettes placed in a thermostated cell
holder at 37 °C. The solutions were stirred continuously. Absorbance
values were transformed into fraction of ﬁbrillar form in the system as
previously described [21].
3. Results and discussion
3.1 In vivo protein aggregation as IBs displays remarkable speciﬁcity
The set of polypeptides that form aggregates inside prokaryotic cells
are not related, either structurally or sequentially [22,23]. This
observation has led to the conception that aggregation into IBs occurs
via non-speciﬁc association of hydrophobic patches on the surface of
folding intermediates. Nevertheless, IBs contain target recombinant
proteins in a highly enriched form, suggesting that in vivo intracellular
aggregation could be a rather speciﬁc process in which recombinant
proteins preferentially associatewith themselves rather thanwith other
polypeptides in the cytoplasm. Supporting this view, we have shown
that the IBs of an aggregation-prone protein are able to act as effective
aggregating cores for the deposition of its soluble, partially folded
counterpart in a dose-dependent manner [14]. Moreover, this incor-
poration is speciﬁc: a particular IB does not recognize soluble hete-
rologous polypeptide chains, suggesting that this process is directed by
selective interactions between the soluble protein chain and its IBs.
To evaluate if this speciﬁcity also applies in the far more complex
cellular environment we measured ﬂuorescence resonance energy
transfer (FRET) between ﬂuorescent proteins via dipole–dipole
coupling [24]. FRET only occurs when the two ﬂuorophores are within
10–100 Å of each other, turning it into a high-resolution approach to
interrogate protein vicinity. Equal amounts of cells expressing different
protein fusions were exposed to the BFP excitation wavelength
(389 nm) and their ﬂuorescence emission is recorded above 420 nm
to detect simultaneously BFP and GFP signals. Control cells expressing
Aβ42-GFP or VP1-GFP exhibit little GFP emission (510 nm) when
excited at 389 nm, as a result of the reduced excitation of the GFP
ﬂuorophore at thiswavelength [25]. In contrast, cells expressing Aβ42-
BFP fusion display a strong, single emission maximum at 445 nm
corresponding to BFP signal (Fig. 1a). When GFP and BFP are co-
expressed in the same cell, the resulting spectra dependon the identity
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of GFP at 510 nm is detected in cells co-expressing Aβ42-GFP+Aβ42-
BFP and in cells co-expressing Vp1-GFP+Aβ42-BFP when they are
excited at 389 nm; but BFP emission decreases only when Aβ42-GFP
and Aβ42-BFP are expressed in the same cell. The ratio betweenemission at the donor and acceptor wavelengths reﬂects both
quenching of donor ﬂuorescence and sensitized emission by the
acceptor. Thus,weused the ratio of GFPﬂuorescence (at 510 nm) to BFP
ﬂuorescence (at 445 nm) to quantify the degree of FRET: 1.5 and 0.9
ratios are obtained for cells expressing the ﬂuorescent proteins fused
to homologous and heterologous aggregation-prone peptides, respec-
tively. This indicates a higher degree of energy transfer and suggests a
higher proximity between the two ﬂuorophores in cells co-expressing
Aβ42-GFP+Aβ42-BFP than in cells co-expressing Vp1-GFP+Aβ42-BFP.
As a negative control, we mixed equal amounts of cells expressing
Aβ42-GFP and cells expressing Aβ42-BFP and excited the mixture at
389 nm. The resulting spectrum is very similar to that of cells
containing only the blue ﬂuorophore, indicating the absence of
signiﬁcant FRET because of the large distance between the different
ﬂuorescent proteins (Fig. 1a).
We wondered if the observed differences in FRET signals reﬂected
distinct biophysical states within the structural organization of the
aggregates formed by the different proteins. To address this issue, cells
co-expressing homologous and heterologous aggregation-prone pep-
tides fused to BFP and GFP were visualized using confocal microscopy
(Fig. 1b). Phase contrast visualization shows that the two types of
aggregates display different morphology. In cells co-expressing Aβ42-
GFP+Aβ42-BFP, IBs appear as typical round shaped refractile structures
at the poles of the cells. In contrast, IBs in cells co-expressing Vp1-GFP+
Aβ42-BFP display an anomalous segmentedmorphologywith the poles
being denser than the inner part. Fluorescence imaging indicates that
this different morphology is related to a non-homogenous distribution
of the tagged aggregation-prone proteins in the IBs. In cells co-
expressing Vp1-GFP+Aβ42-BFP, the green ﬂuorescence signal is
concentrated at the poles, coincident with the dense regions observed
by phase contrast, whereas the blue ﬂuorescence is distributed homo-
genously in the IB. This means that the external part of IBs is selectively
enriched with aggregated Vp1-GFP protein. No segregation of ﬂuo-
rescent tags can be observed in the IBs of cells co-expressing Aβ42-GFP
and Aβ42-BFP fusions: they exhibit homogeneous and overlapping
ﬂuorescence signals.
To corroborate these results, FRET has been quantiﬁed over the
confocal microscopy samples. A widely used approach for FRET quan-
tiﬁcation consists on the measurement of the increase in the ﬂuo-
rescence intensity of the donor after acceptor photobleaching. Because
the excitation light used to bleach the acceptor usually does not bleach
the donor efﬁciently, the FRET quantiﬁcation by this approach is less
affected by cross-talk. Energy transfer efﬁciency depends not only on
the distance between the donor and acceptor but also on the relative
orientation of their transitional dipole moments and thus aggregation
might, in principle, affect the FRET signal. Nevertheless, Petersen and
co-workers have demonstrated that intermolecular energy transfer
efﬁciency depends only slightly on the degree of aggregation [26],
validating our approach. In our samples, the efﬁciency of FRET is
measured in IB regions in which green and blue ﬂuorescence
apparently colocalize (100 independent measurements for each type
of aggregate). As it is plotted in Fig. 1c, the FRET percentage is nearly
three fold higher in the aggregates of cells co-expressing Vp1-GFP+Fig. 1. Speciﬁcity in IBs formation. (a) FRET efﬁciency between BFP and GFP measured in
live E. coli cells by recording the ﬂuorescence spectra between 400 and 600 nm after
excitation of BFP at 389 nm. The emission maxima of BFP and GFP are indicated. The
expressed protein fusions are indicated in the legend. Brackets indicate an equal
mixture of cells expressing the different fusions. (b) Confocal ﬂuorescence imaging of
cells expressing Aβ42-BFP+Aβ42-GFP or Aβ42-BFP+Vp1-GFP. BFP signal is displayed in
red for better visualization. The images from left to right correspond to phase, GFP
channel, BFP channel, merged images of BFP and GFP channels and merged images of
GFP channel and phase. IBs can be observed inside the cells as refractile structures.
When Aβ42-BFP and Vp1-GFP are co-expressed, the green ﬂuorescence is more intense
in the poles of the IBs coinciding with a higher density region pointed by arrows in the
phase contrast image. (c) FRET efﬁciency in the aggregates of cells expressing Aβ42-BFP
+Aβ42-GFP or Aβ42-BFP+Vp1-GFP as measured in confocal microscopy samples.
Fig. 2. IBs stability and composition. (a) Kinetics of solubilization in the presence of
GuHCl of IBs formed by the proteins indicated in the legend and monitored by the
measurement of turbidity at 350 nm. (b) Change in composition of IBs along time. The
insoluble fraction of cells expressing Vp1-GFP+Aβ42-BFP was isolated and analyzed by
SDS-PAGE. The percentage of each fusion protein is plotted versus the time after
induction of protein expression.
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different aggregation-prone peptides. Hence, although no absolute
compartmentalization of the two ﬂuorescent proteins is detected, the
observed decrease in FRET efﬁciency would reﬂect a larger mean
distance between Aβ42-BFP and Vp1-GFP inside IBs.
Our data demonstrate that, in vivo, different classes of proteins
which become associated in aggregates exhibit distinct molecular
interactions and do not necessarily co-aggregate. A similar degree of
selectivity during co-aggregation of proteins has been shown in the
formation of aggresomes inside mammalian cells in vivo [9]. However,
aggregation in eukaryotic environments is linked to a dynein-
dependent retrograde transport on microtubules, which might modu-
late somehow the speciﬁcity of the process. To the best of our know-
ledge, this is the ﬁrst time that speciﬁcity is proved during in vivo
protein aggregation in a prokaryotic organism. This observation
suggests the existence of evolutionary conserved adaptations in living
systems towards restricting non-speciﬁc aggregation of misfolded
proteins that escape the protein quality control under a range of
environmental and physiological stresses.
3.2. Intracellular aggregates display differential stability
If, as deduced from the data presented above, the molecular
interactions in Vp1-GFP+Aβ42-BFP IBs are different from those in
Aβ42-GFP+Aβ42-BFP IBs, the two types of aggregates might exhibit
structures displaying different stability. One method to determine IBs
stability is the kinetic studyof their solubilization bya chaotropic agent
[20] like guanidinium hydrochloride (GuHCl), monitoring the change
in turbidity (A350) over time (Fig. 2a). The data obtained can be ﬁtted to
a double-exponential decay equation with good accuracy (RN0.99)
allowing the calculation of the apparent rate constants of the fast
phase. Differences in the velocity of solubilization could be observed
between both samples with the following fast rate constants: 0.113±
0.001 00 min−1 (Aβ42-GFP+Aβ42-BFP) and 0.127±0.001 00 min−1
(Aβ42-BFP+Vp1-GFP). From these data, it follows that homogeneity
promotes cohesiveness in the aggregates because the structure is glued
through a network of homologous intermolecular contacts. On the
other hand, in heterogeneous IBs, segregation and distance between
the different species would difﬁcult the establishment of solid
intermolecular bonds resulting in less stable structures. Overall, it
seems that, ultimately, intracellular aggregates structure depends on
the degree of speciﬁcity of the contacts established between
aggregating polypeptide chains during the deposition process.
3.3. Kinetic control of intracellular protein aggregation
The formation of IBs is considered to be a diffusion-limited process.
Therefore, even if twodifferent proteins ﬁnally accumulate in the same
IB, if one of them aggregates faster, it will effectively exclude the other
one from being incorporated in the core of the aggregate. Several
algorithms as AGGRESCAN [27] or TANGO [28] aim to predict the
relative aggregation tendencies of polypeptides. Both programs
predict the aggregation propensity of Aβ42-GFP to be higher than
that of Vp1-GFP. Thismight result in different aggregation kinetics and
could explain the differential location of both proteins in the
aggregates. To conﬁrm this point, the relative amount of both peptides
in the insoluble cellular fraction was determined at selected time
points (Fig. 2b). Even if the two proteins are expressed under the same
promoter, the initial aggregates contain over 80% of Aβ42-BFP,
indicating that this fusion aggregates in vivo faster than Vp1-GFP and
forms the core of mixed IBs. The percentage of insoluble Vp1-GFP
increases progressively probably by deposition on the outer face of the
aggregates. The IBs composition evolves along the time to reach
equilibrium around 10 h after protein expression induction in which
Aβ42-BFP and VP1-GFP constitute around 60% and 40% of the protein
in the aggregates, respectively.It seems that in vivo kinetic partitioning can exert a tight control
on the distribution of proteins in intracellular aggregates being
responsible for the preferential localization of Vp1-GFP at the poles of
mixed aggregates. The observed kinetic segregation indicates that
proteins tend to aggregate independently in vivo, and suggests that
speciﬁc contacts are responsible for this behaviour. The observed
segregation is even more striking if one takes into account that Aβ42-
BFP and Vp1-GFP share the ﬂuorescent protein domain, and that the
establishment of contacts between unfolded or partially folded BFP
and GFP moieties during aggregation cannot be discarded. This
observation supports selectivity during intracellular deposition in
physiological conditions, where proteins are expressed at much lower
levels and usually do not share high sequence identities neither
display topologically similar native structure or folding intermedi-
ates. This speciﬁcity would be an effective strategy to avoid abnormal
interactions of misfolded proteins with normal cellular constituents
in the highly crowded cell cytoplasm.
3.4. Proteolytic digestion of inclusion bodies
For a long time, the inner architecture of IBs has been considered
amorphous. However our in vitro and in vivo data suggest that aggre-
gation is the result of rather selective interactions between
Fig. 3. Proteinase K digestion of IBs. Kinetics of Aβ42-GFP IBs ﬂuorescence and turbidity
decrease in the presence of PK. A progressive disappearance of the SDS-PAGE Aβ42-GFP
band can be noticed in agreement with ﬂuorescence and turbidity data.
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some degree of internal order in the ﬁnal aggregate, as it occurs in
amyloid ﬁbrils. Interestingly enough, natural and de novo designed
amyloidogenic proteins usually aggregate as IBs when they are
expressed in E. coli [29,30]. Consistently, if their amyloid propensity
is reduced, their intracellular aggregation decreases [31,32] and vice
versa [33]. These data suggest that the intermolecular interactions that
drive proteins to associate in vitro as ﬁbrils could be related to those
favouring aggregation as IBs, which might imply certain similarity in
the inner organization of both types of aggregates. However, IBs can
contain signiﬁcant amounts of functional polypeptides [11,34]. It is still
controversial the way in which active and inactive polypeptides can
coexist in cytoplasmic aggregates. The possibility that single polypep-
tide chains might simultaneously display misfolded protein regions
engaged in the β-sheet architecture of IBs and properly folded
functional domains is still under discussion. Enzymes and ﬂuorescentFig. 4. Fibrillar structure of Aβ42-GFP IBs. The ﬁrst ﬁgure on the left is a micrograph of puriﬁe
represents 500 nm.proteins have been successfully attached in their active forms to
aggregated amyloidﬁbrils [35–37], suggesting that this organization of
domains might exist in other type of macromolecular aggregates. In
the last times, several groups are using solid-state NMR as a high-
resolution approach to study in situ the conformational states of
polypeptides within IBs. Unfortunately, no high-quality 3D informa-
tion on the structure of such intracellular aggregates is available yet.
To gain insights into the molecular organization of IBs, we have
taken advantage of the broad speciﬁcity of proteinase K (PK). This
protease has found its application in mapping the core of amyloid
structures, because it is highly active against globular domains or
disordered regions but displays low activity against the densely
packed cross-β-conformations residing inside amyloids [38]. We
added PK to puriﬁed Aβ42-GFP IBs and measured its accessibility to
properly folded domains in the aggregates by monitoring the IBs GFP
ﬂuorescence emission along time. As it is shown in Fig. 3, PK promotes
a gradual loss of the ﬂuorescent signal that is complete after 10 min of
reaction. An SDS-PAGE analysis of the digestion shows a concomitant
disappearance of the Coomassie-stained band corresponding to Aβ42-
GFP. The PK effect on Aβ42-GFP IBs compactness has been monitored
by light scattering. PK promotes a gradual decrease in the turbidity of
the solution indicative of a disintegration of the initial aggregates,
which is completed after 10 min (Fig. 3). The parallel kinetics of light
scattering and ﬂuorescence suggest two possibilities concerning the
organization of polypeptides in IBs. First, active (ﬂuorescent) and
inactive protein regions can be mixed and organized in a structure
that is homogenously sensitive to proteolysis. Therefore, the inactiva-
tion of functional domains would coincide with the global disintegra-
tion of the aggregate yielding similar kinetics for ﬂuorescence loss and
light scattering. A second possibility is that only the digestion of a
fraction of the protein embedded in the aggregate is monitored,
whereas another part remains resistant. In this case, the ﬂuorescence
data would imply that the protease sensitive regions include poly-
peptides displaying a conformation compatible with ﬂuorescence. In
this scenario, it is tempting to speculate that the PK-resistant struc-
tures could correspond to the intermolecular β-sheets recurrently
observed in IBs.d IBs. The rest of images are micrographs of IBs after PK proteolytic action. The scale bar
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To distinguish between the two above-mentioned structural possi-
bilities, we have used TEM and AFM to explore the morphology of the
aggregates before and after adding PK. InTEM images, intact Aβ42-GFP
IBs display the typical electron-dense ellipsoidal shape and no ﬁbrillar
species are detected. In contrast, in samples incubated with PK, the
presence of abundant ﬁbrillar structures connecting apparently amor-
phous regions is observed (Fig. 4). These ﬁbrils are not organized as a
tight assembly, but they form a loose network. The size and morpho-
logy of these structures are compatible with an amyloid-like nature. If
the observed ﬁbrillar structures include Aβ42 polypeptide regions in
the IBs, the same kind of structures should be observed in IBs formed
by the Aβ42 peptide without any fusion (Aβ42-only). To test this
hypothesis, we expressed Aβ42 in E. coli. The IBs formed by Aβ42-only
are smaller (0.3 μm) than those formed by the Aβ42-GFP fusion
(1.0 μm) (Fig. S1 in supplementarymaterials). Incubation of Aβ42-only
IBs with PK also results in formation of ﬁbrillar structures, as observed
by TEM (Fig. 5). Images of early digestion times show that this ﬁbrillar
material protrudes from the surface of the aggregates, suggesting the
existence of ordered PK resistant cores with ﬁbrillar structure inside
the aggregates formed in the prokaryotic cytoplasm. These data
provide one of the ﬁrst direct evidences for the existence of amyloid-
like ﬁbrillar structure inside prokaryotic intracellular aggregates.
AFM has been used for the study of several protein systems that
form amyloids [39]. Recently it has been reported its use for the
analysis of mammalian intracellular aggregates [40], but no data
referring to its application in prokaryotic aggregates is still available. InFig. 5. Fibrillar structure of Aβ42-only IBs. Micrographs of Aβ42-onlycontrast toTEM,AFMallows direct observation of protein aggregates in
solution and permits following the morphology of individual mole-
cules and aggregates along time. When AFM is applied to investigate
the time course of IBs PK digestion, a ﬁrst surprising observation is that
aggregates in close vicinity react very differently in front of PK treat-
ment (Fig. 6). Whereas some aggregates become largely disassembled,
others remain essentially intact. The different behaviour in front of PK
digestion suggests heterogeneity in the internal structure which may
arise, among other factors, from variations in the environment and
aggregate growth conditions. We can speculate that each aggregate
comes from an individual cell and differences in expression levels
between cells or differing metabolic states in different cells might
result in aggregates with different properties. Accordingly, cell-to-cell
heterogeneity in the molecular interactions of intracellular agreggates
formedbypolyglutamine fusions inside human cells has been reported
[41]. In agreement with TEM data, the action of the protease in PK
sensitive aggregates promotes the progressive appearance of elon-
gated structures with heights ranging from 2 to 5 nm, consistent with
the dimensions of amyloid protoﬁlaments and ﬁbrils [42] (Fig. 6).
The above discussed data indicate indicate the coexistence in pro-
karyotic IBs of PK-resistant ﬁbrillar structures and less packed regions
sensitive to proteolytic attack. Using the AFM tip as force sensor, force-
distance curves can be obtained that provide information on single-
molecule or -particle rupture forces. When applying such force spec-
troscopy approach, indentations of IBs before and after PK treatment
reveal that freshly prepared IBs have regions opposing relatively
strong resistance to indentation, together with other softer areas
(Fig. 7a). However, PK removes completely the hardest zones from theIBs after PK proteolytic action. The scale bars represent 200 nm.
Fig. 6. Amplitude AFM images of individual Aβ42-GFP IBs digested with PK. A group of IBs deposited on graphite is imaged at the start of the experiment (0min), 30min after addition
of a ﬁrst PK aliquot (1× PK), and 20 min after the addition of a second PK aliquot (2× PK). Note the ﬁbril-like structures that settle on the graphite surface as digestion progresses
indicated with white arrows. Lines indicate the path of the topographic proﬁles shown below that illustrate the differences in susceptibility to PK digestion between the two largest
IBs. Arrowheads indicate the points that deﬁne the height measurements in nm.
Fig. 7. Force spectroscopy analysis of Aβ42-GFP IBs. (a) A single IB was indented with an AFM tip before (left panel) and after (right panel) PK treatment. The inset height AFM images
show the appearance on the graphite surface of abundant ﬁbrillar material after PK digestion. The two histograms represent the forces required to penetrate IBs in both samples. The
group of indentations centered at ca. 500 pN in pre-PK samples is totally absent from post-PK assays, indicating that PK treatment has eliminated from the IBs preexisting harder
inner areas. (b) Combined force spectroscopy-ﬂuorescence analysis the effect of PK treatment on IBs. (A–C) GFP ﬂuorescence of IBs immediately after deposition on the PMMA surface
(A), and immediately before indentation without PK treatment (B), and after PK digestion (C). (D–F) An individual IB without PK treatment before (D) and after indentation (E), and
the same IB indented again after PK treatment (F). The indentation paths before and after PK treatment are indicated by an arrow and an arrowhead, respectively. (G, H) Analysis of 10
individual approaching curves for the indentations performed on the IB from panels D–F before (G) and after PK treatment (H).
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Fig. 8. Spectroscopic analysis of IBs structure. (a) FT-IR spectrum of the PK resistant
fraction of Aβ42-GFP IBs. The position of the spectral components is estimated from the
second derivative. β-sheet related bands (at 1625 cm−1 and 1692 cm−1) are indicated by
arrows. (b) Th-T binding to Aβ42-GFP IBs before and after PK digestion.
Fig. 9. Intracellular oligomerization and ﬁbril seeding by IBs. (a)Western Blot analysis of
GFP to detect the presence of SDS-resistant oligomeric species in the insoluble (I) and
soluble (S) cell fractions of cells expressing Aβ42-GFP at different times after IPTG
addition. Molecular weight markers (kDa) are indicate on the left of the blot. (b)
seeding-dependent maturation of synthetic Aβ42 peptide amyloid ﬁbril growth
monitored through Th-T ﬂuorescence emission. The ﬁbrilar fraction of Aβ42 is
represented as a function of time. The formation of Aβ42 amyloid ﬁbrils is accelerated
by the addition of Aβ42 preformed ﬁbrils (10% w/w) or Aβ42-only IBs (OD350=0.125).
1823M. Morell et al. / Biochimica et Biophysica Acta 1783 (2008) 1815–1825IBs simultaneously with the release of the amyloid-like ﬁbrils.
Analysis of individual approaching curves for the indentations
performed before and after PK treatment reveals astonishing
differences. Indentations on PK-treated IBs yield a typical proﬁle of
progressive penetration with increasing load. Before PK digestion, on
the other hand, the AFM tip penetrates the IBs once the applied load
overcomes the resistance of the structure, but surprisingly, the AFM
tip is apparently pushed off the IB until much greater loads of ca. 6 nN
ﬁnally penetrate the IB again (Fig. 7b). This result strongly suggests
internal rearrangements of the IB that might rebuild strong structures
temporarily disrupted by the indenting AFM tip. This indicates that
the ﬁbrillar material confers resistance to IBs in front of indentation
and conﬁrms the existence of structural diversity inside the
aggregates.
3.6. Amyloid-like properties of inclusion bodies
Fourier-transform infrared (FT-IR) spectroscopy has proved to be a
powerful tool for the investigation of secondary structure in
aggregated proteins [13,43]. The amide I band essentially corresponds
to the absorption of the carbonyl peptide bond group of the protein
main chain and is, therefore, a sensitive marker of the protein
secondary structure. The second derivative of FT-IR spectra of the
Aβ42-GFP IBs PK-resistant material in the amide I region is dominated
by two bands at 1625 cm−1 and 1692 cm−1, which are indicative of the
presence of extended intermolecular β-sheet structures in the ﬁbrillar
aggregates (Fig. 8a). The component at 1621 cm−1 indicates that thepolypeptide backbones involved in the β-sheet architecture are tightly
packed, sharing short hydrogen bonds. The presence and relative
position of these two bands is generally used as a diagnostic tool for
the existence of cross-β-structure in most amyloid ﬁbrils [44].
Therefore, it appears that the formation of an inter-backbone
hydrogen-bonded network leading to the formation of similar ﬁbrillar
structures enriched in β-sheet conformation in diferent aggregates
constitutes a common driving force for protein deposition. This
statement seems reasonable because all polypeptides have in
common the polypeptide backbone, regardless of their sequence.
Thepresence of intermolecular crossedβ-pleated sheet structure in
amyloid ﬁbrils can be detected using Th-T, a speciﬁc marker for this
conformation [45]. As we have demonstrated before for several IBs
[14,46], puriﬁed Aβ42-GFP aggregates bind to Th-T. Treatment of the
aggregates with PK triggers a two-fold increase in the typical emission
maximum at 485 nm (Fig. 8b). In agreement with TEM, AFM and FTIR
data, this proteolysis-promoted effect is likely the result of exposure to
the solvent and increased accessibility to Th-T of previously hidden
ﬁbrilar structures displaying β-sheet structure.
Preliminary mass spectrometry analysis of the PK-resistant mate-
rial in Aβ42-GFP IBs suggests that, in addition to Aβ42, the aggre-
gation-prone regions of someGPF polypeptide chains are embedded in
the ﬁbrillar core (Fig. S2 in supplementary material). Although un-
expected, this result is consistent with the observation that for
chimeric polyglutamine-containing proteins, regions from both the
aggregation-prone polyQ ladder and the attached globular protein are
found in the core of bacterial aggregates [47]. The presence of
aggregated GFP chains in Aβ42-GFP IBs might endow them with
additional intermolecular contacts, relative to those established by the
Aβ42 moiety. This will explain why Aβ42-only IBs are less stable in
front of chemical denaturation than Aβ42-GFP IBs. Nevertheless, the
Aβ42 motif still constitutes the main contributor to Aβ42-GFP IBs
structure, sinceVp1-GFP IBs are exceedingly less stable thanAβ42-GFP,
or Aβ42-only, IBs (Fig. S3 in supplementarymaterial). It is possible that,
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and the aggregation-prone regions in our fusions do not behave
completely independently but mutually affect each other's aggrega-
tion behaviour inside the cell.
A wealth of data converge to indicate that the early steps in the
ﬁbrilization pathway of Aβ42 involve the formation of non covalent,
SDS-resistant oligomers [49]. These species are also detected in
mammalian cell culture, and in the human brain [50]. Interestingly,
the expression in yeast of Aβ42 fused to the globular domain of the
Sup35 prion rendered SDS-stable oligomers [51].Western blot analysis
of GFP demonstrates the formation of high molecular weight, SDS-
stable, oligomers in E. coli cells producing Aβ42-GFP shortly after
induction of protein expression (Fig. 9a). This observation adds
evidence to the hypothesis that the molecular pathways that drive
proteins to associate in vitro as ﬁbrils are the same that also favour
aggregation as intracellular aggregates in both eukaryotic and pro-
karyotic environments.
It is well established that the rate of ﬁbril formation by an amyloi-
dogenic protein is enhanced by the addition of preformed ﬁbrils, a
phenomenon known as seeding. This effect has been associated with
the transmission of the TSEs and with the rapid development of
Alzheimer's disease once clinical symptoms are detected [52,53].
Seeding displays a high sequence speciﬁcity and protein aggregation
can be nucleated by homologous ﬁbrils, but not by ﬁbrils from closely
related sequences [54]. This behaviour is thought to be the cause that
proteins deposited in amyloid diseases are typically composed of a
single primary polypeptide rather than resulting from the widespread
recruitment of other amyloidogenic proteins present within the body.
More relevant for our study is the recent observation that the amino
acid sequence is important only insofar as it confers a preference for a
particular ﬁbril conformation and that it is in fact ﬁbril conformation
which correlates with seeeding capability [6]. This observation pro-
vides us with a unique tool to demonstrate that intracellular pro-
karyotic aggregates display amyloid conformations. We assayed
whether Aβ42-only IBs are able to speciﬁcally seed the formation of
amyloid ﬁbrils by a synthetic Aβ42 peptide monitoring the changes in
Th-T ﬂuorescence emission as a function of time. The formation of
amyloid ﬁbrils by synthetic Aβ42 peptide at 10 μM follows a cha-
racteristic sigmoid curve displaying a nucleation phase of 251 min in
which no increase in ﬂuorescence is detected, followed by a fast ﬁbril
growth phase that reaches a plateu after 380 min of incubation. Seed-
ing the reactionwith 10% of in vitro preformed Aβ42 ﬁbrils completely
abrogates the lag phase and the ﬁbril formation reaction is completed
after only 12 min. Importantly, the addition of puriﬁed Aβ42-only IBs
also seeds Aβ42 peptide ﬁbril formation, signiﬁcantly reducing the
nucleationphase to 105min and allowing the reaction to be completed
in 285 min (Fig. 9b). Thus, the polypeptides embedded in the IBs can
speciﬁcally recognize soluble Aβ42 peptide molecules and promote
their ﬁbrillization into β-sheet-rich structures.
Two recent independentworks have demonstrated the existence of
ﬁbrillar structure in the intracellular aggregates formed by polyQ-GFP
fusions inside mammalian cells [55,56]. Our data indicate that this
property is not restricted to disease-linked eukaryotic aggregates, but
is rather a general property of the intracellular inclusions formed by
aggregation-prone polypeptides, independent of the cellular back-
ground, as demonstrated by the fact that the prokaryotic intracellular
aggregates and amyloid ﬁbrils of a given protein share conformational
andmechanistic features. In addition, it is shown that, as in eukaryotes,
the formation of prokaryotic aggregates exhibits an important in vivo
speciﬁcity even among extremely aggregating substrates expressed at
very high levels.
In many conformational disorders, aggregation-prone, causative
proteins are incorporated into intracellular microscopic IBs. For that
reason, these intracellular aggregates have been suspected as the toxic
structures associated to the disease. However, the onset of cell
dysfunction has been found to be independent of the formation of IBs[57]. In addition, recent data suggest that pre-aggregated, diffusible
assemblies are the most harmful species and that in fact high order
aggregates might display a protective role [58]. In this later scenario,
because all organisms face challenges of protein misfolding and
aggregation, it is not surprising the existence of an evolutionary
conserved strategy to avoid the harmful effects of undesired protein
aggregation by sequestering sticky folding intermediates into
conformationally related stable aggregated structures through
selective interactions. Accordingly, the protein quality control
machinery genes modulating this process are highly conserved
across species. Therefore, prokaryotic systems should be seriously
considered when exploring the in vivo determinants and cellular
effects of protein aggregation. Two recent examples illustrating this
statement are the demonstration that conformational stability
controls in vivo globular protein aggregation and that the segrega-
tion of protein aggregates in the cell is associated with cellular aging
and rejuvenation, both conclusions resulting from the study of
aggregation in bacterial backgrounds [47,59].
The formation in E. coli of SDS-resistant oligomers and ﬁbrillar
structures able to seed amyloid ﬁbril formation raise important safety
concerns relative to the biotechnological and biomedical applications
of recombinant polypeptides, especially for aggregation-prone mole-
cules, since the exposure to exogenous substances with amyloid
enhancing potential may be an important epigenetic or environ-
mental factor in the development of amyloidosis in a susceptible
population [60].
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